Carregant...
Manipulating the epigenome for the treatment of urological malignancies(,)
Urological malignancies (cancers of the prostate, bladder, kidney and testes) account for 15% of all human cancers and more than 500,000 deaths worldwide each year. This group of malignancies is spread across multiple generations, affecting the young (testicular) through middle and old-age (kidney,...
Guardat en:
| Publicat a: | Pharmacol Ther |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5176100/ https://ncbi.nlm.nih.gov/pubmed/23353098 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2013.01.007 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|